[go: up one dir, main page]

SI1173194T1 - Recombinant sp-a for the treatment or prevention of pulmonary infection and inflammation - Google Patents

Recombinant sp-a for the treatment or prevention of pulmonary infection and inflammation

Info

Publication number
SI1173194T1
SI1173194T1 SI200030474T SI200030474T SI1173194T1 SI 1173194 T1 SI1173194 T1 SI 1173194T1 SI 200030474 T SI200030474 T SI 200030474T SI 200030474 T SI200030474 T SI 200030474T SI 1173194 T1 SI1173194 T1 SI 1173194T1
Authority
SI
Slovenia
Prior art keywords
inflammation
prevention
treatment
recombinant
pulmonary infection
Prior art date
Application number
SI200030474T
Other languages
English (en)
Slovenian (sl)
Inventor
Klaus Melchers
Klaus Schaefer
Wolfram Steinhilber
Jeffrey Whitsett
Ann Marie Levine
Thomas Korfhagen
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Publication of SI1173194T1 publication Critical patent/SI1173194T1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/785—Alveolar surfactant peptides; Pulmonary surfactant peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SI200030474T 1999-01-19 2000-01-18 Recombinant sp-a for the treatment or prevention of pulmonary infection and inflammation SI1173194T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15526899P 1999-01-19 1999-01-19
PCT/EP2000/000324 WO2000043026A2 (en) 1999-01-19 2000-01-18 Recombinant sp-a for the treatment or prevention of pulmonary infection and inflammation
EP00912431A EP1173194B1 (en) 1999-01-19 2000-01-18 Recombinant sp-a for the treatment or prevention of pulmonary infection and inflammation

Publications (1)

Publication Number Publication Date
SI1173194T1 true SI1173194T1 (en) 2004-12-31

Family

ID=22554732

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200030474T SI1173194T1 (en) 1999-01-19 2000-01-18 Recombinant sp-a for the treatment or prevention of pulmonary infection and inflammation

Country Status (11)

Country Link
US (2) US7135452B1 (da)
EP (1) EP1173194B1 (da)
AT (1) ATE269101T1 (da)
AU (1) AU774207B2 (da)
CA (1) CA2361276A1 (da)
DE (1) DE60011601T2 (da)
DK (1) DK1173194T3 (da)
ES (1) ES2223478T3 (da)
PT (1) PT1173194E (da)
SI (1) SI1173194T1 (da)
WO (1) WO2000043026A2 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2405811C (en) * 2000-04-12 2011-09-27 Altana Pharma Ag Novel use of pulmonary surfactant for the prophylaxis or early treatment of acute pulmonary diseases
SE0203591D0 (sv) * 2002-12-04 2002-12-04 Siemens Elema Ab Förfarande för beredning av ett mediakament och en medicinsk anordning
RU2238757C1 (ru) * 2003-06-24 2004-10-27 ООО "Биосурф" Способ лечения ингаляционных поражений
WO2007111496A1 (en) * 2006-03-28 2007-10-04 Universiteit Utrecht Holding B.V. Improved carbohydrate recognition domains
EP2170270B1 (en) * 2007-06-05 2016-01-13 Paka Pulmonary Pharmaceuticals, Inc. Compositions for delivering medicaments into the lungs, uses thereof
EP2370068A4 (en) 2008-12-10 2015-09-23 Paka Pulmonary Pharmaceuticals Inc METHOD AND COMPOSITIONS FOR DELIVERING MEDICAMENTS TO THE LUNG
WO2012061750A2 (en) * 2010-11-04 2012-05-10 The Board Of Regents Of The University Of Oklahoma Peptide compositions that downregulate tlr-4 signaling pathway and methods of producing and using same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840527A (en) * 1984-12-11 1998-11-24 Byk Gulden Lomberg Chemische Fabrik Gmbh Recombinant alveolar surfactant protein
US4659805A (en) * 1984-12-11 1987-04-21 California Biotechnology, Inc. Recombinant alveolar surfactant protein
US4912038A (en) * 1984-12-11 1990-03-27 California Biotechnology Inc. Recombinant DNA sequence encoding alveolar surfactant protein
US4882422A (en) * 1985-10-24 1989-11-21 Genetics Institute, Inc. Pulmonary surfactant proteins
WO1988005820A1 (en) * 1987-01-29 1988-08-11 California Biotechnology, Inc. Recombinant alveolar surfactant protein
JP3961029B2 (ja) 1992-06-24 2007-08-15 博 木戸 インフルエンザウィルス感染防止剤
US6267958B1 (en) * 1995-07-27 2001-07-31 Genentech, Inc. Protein formulation

Also Published As

Publication number Publication date
AU774207B2 (en) 2004-06-17
WO2000043026A3 (en) 2001-10-18
EP1173194B1 (en) 2004-06-16
CA2361276A1 (en) 2000-07-27
ES2223478T3 (es) 2005-03-01
DE60011601D1 (de) 2004-07-22
DK1173194T3 (da) 2004-10-18
US7135452B1 (en) 2006-11-14
ATE269101T1 (de) 2004-07-15
WO2000043026A2 (en) 2000-07-27
PT1173194E (pt) 2004-10-29
DE60011601T2 (de) 2005-07-07
AU3420900A (en) 2000-08-07
US20060194732A1 (en) 2006-08-31
EP1173194A2 (en) 2002-01-23

Similar Documents

Publication Publication Date Title
IL139002A0 (en) Compositions for the treatment of hiv and other viral infections
UA56989C2 (uk) ФІЗІОЛОГІЧНО АКТИВНИЙ ПЕГ-КОН'ЮГАТ <font face="Symbol">a</font>-ІНТЕРФЕРОНУ, СПОСІБ ЙОГО ОДЕРЖАННЯ, ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ НА ЙОГО ОСНОВІ ТА СПОСІБ ЛІКУВАННЯ АБО ПРОФІЛАКТИКИ ІМУНОМОДУЛЯТОРНИХ ЗАХВОРЮВАНЬ
HUP0100669A3 (en) Peptide derivatives as serine protease inhibitors, their use and pharmaceutical compositions comprising thereof
TWI318116B (en) Pharmaceutical compositions for treatment or prophylaxis of viral infections comprising novel aspartyl protease inhibitors and additional anti-viral agents
AU1067599A (en) Peptide compositions for the treatment and prevention of hiv infection
AU2002248319A1 (en) Pharmaceutical composition for the prevention and treatment of scar tissue
HUP0200821A3 (en) Composition for the preservation of infectious recombinant adenoviruses
SI1173194T1 (en) Recombinant sp-a for the treatment or prevention of pulmonary infection and inflammation
AU2002219881A1 (en) Methods and compositions for the treatment of human immunodeficiency virus infection
AU5006499A (en) Compositions and methods for the treatment or prevention of pulmonary infections
IL152202A0 (en) Human kcnq5 polypeptide and pharmaceutical compositions containing the same
AU2002322082A1 (en) Pharmaceutical composition for the treatment of viral infection
AU2002325169A1 (en) Pharmaceutical composition for the prophylaxis and/or treatment of virus diseases
AU4644299A (en) Synthetic peptides and pharmaceutical compositions comprising them for diagnosisand treatment of anti-phospholipid syndrome
AU1878201A (en) Composition for the treatment of damaged tissue
AU4568400A (en) Sphingomyelinase inhibitor
AU6179600A (en) Peptides and pharmaceutical compositions comprising same
IL156711A0 (en) Peptide derivatives and pharmaceutical compositions containing the same
SI1276495T1 (sl) Uporaba rekombinantnega pljucnega surfaktanta za zgodnje zdravljenje akutnih pljucnih bolezni
AU2002230129A1 (en) Novel physiologically active peptide and use thereof
GB9802542D0 (en) New use
EE200000694A (et) Inimese rekombinantse iterferooni beeta-1a (IFN-ß-1a) formulatsioon
ZA971036B (en) Pharmaceutical compositions for the prevention or treatment of retrovirus infections.
BG103859A (en) The use of 1-ar(alk)yl-imidazolin-2-on for the treatment of fear and stress conditions
AU3524700A (en) Prevention and treatment of viral infections